303 related articles for article (PubMed ID: 33205065)
21. New insights into HDV persistence: The role of interferon response and implications for upcoming novel therapies.
Zhang Z; Urban S
J Hepatol; 2021 Mar; 74(3):686-699. PubMed ID: 33276031
[TBL] [Abstract][Full Text] [Related]
22. Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice.
Giersch K; Homs M; Volz T; Helbig M; Allweiss L; Lohse AW; Petersen J; Buti M; Pollicino T; Sureau C; Dandri M; Lütgehetmann M
Sci Rep; 2017 Jun; 7(1):3757. PubMed ID: 28623307
[TBL] [Abstract][Full Text] [Related]
23. Circulation of hepatitis delta virus and occult hepatitis B virus infection amongst HIV/HBV co-infected patients in Korle-Bu, Ghana.
Attiku K; Bonney J; Agbosu E; Bonney E; Puplampu P; Ganu V; Odoom J; Aboagye J; Mensah J; Agyemang S; Awuku-Larbi Y; Arjarquah A; Mawuli G; Quaye O
PLoS One; 2021; 16(1):e0244507. PubMed ID: 33411715
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis delta virus facilitates the selection of hepatitis B virus mutants in vivo and functionally impacts on their replicative capacity in vitro.
Shirvani-Dastgerdi E; Pourkarim MR; Herbers U; Amini-Bavil-Olyaee S; Yagmur E; Alavian SM; Trautwein C; Tacke F
Clin Microbiol Infect; 2016 Jan; 22(1):98.e1-98.e6. PubMed ID: 26433026
[TBL] [Abstract][Full Text] [Related]
25. Current knowledge on Hepatitis Delta Virus replication.
Lucifora J; Delphin M
Antiviral Res; 2020 Jul; 179():104812. PubMed ID: 32360949
[TBL] [Abstract][Full Text] [Related]
26. Dynamics of in vivo hepatitis D virus infection.
Goyal A; Murray JM
J Theor Biol; 2016 Jun; 398():9-19. PubMed ID: 27012516
[TBL] [Abstract][Full Text] [Related]
27. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
Yan H; Peng B; Liu Y; Xu G; He W; Ren B; Jing Z; Sui J; Li W
J Virol; 2014 Mar; 88(6):3273-84. PubMed ID: 24390325
[TBL] [Abstract][Full Text] [Related]
28. Cell Culture Models for Hepatitis B and D Viruses Infection: Old Challenges, New Developments and Future Strategies.
Carpentier A
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793598
[TBL] [Abstract][Full Text] [Related]
29. Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line.
Wu JC; Chen PJ; Kuo MY; Lee SD; Chen DS; Ting LP
J Virol; 1991 Mar; 65(3):1099-104. PubMed ID: 1847439
[TBL] [Abstract][Full Text] [Related]
30. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J
Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
[TBL] [Abstract][Full Text] [Related]
31. HepG2BD: A Novel and Versatile Cell Line with Inducible HDV Replication and Constitutive HBV Expression.
Blanchet M; Angelo L; Tétreault Y; Khabir M; Sureau C; Vaillant A; Labonté P
Viruses; 2024 Mar; 16(4):. PubMed ID: 38675875
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis-D Virus Infection Is Not Impaired by Innate Immunity but Increases Cytotoxic T-Cell Activity.
Altstetter SM; Quitt O; Pinci F; Hornung V; Lucko AM; Wisskirchen K; Jung S; Protzer U
Cells; 2021 Nov; 10(11):. PubMed ID: 34831475
[TBL] [Abstract][Full Text] [Related]
33. Analysis of Host Responses to Hepatitis B and Delta Viral Infections in a Micro-scalable Hepatic Co-culture System.
Winer BY; Gaska JM; Lipkowitz G; Bram Y; Parekh A; Parsons L; Leach R; Jindal R; Cho CH; Shrirao A; Novik E; Schwartz RE; Ploss A
Hepatology; 2020 Jan; 71(1):14-30. PubMed ID: 31206195
[TBL] [Abstract][Full Text] [Related]
34. Co-expression of markers for hepatitis delta and hepatitis B viruses in human liver.
Ryley NG; Heryet AR; Goldin R; Monjardino J; Saldanha J; Fleming KA
Histopathology; 1992 Apr; 20(4):331-7. PubMed ID: 1577410
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study.
Hønge BL; Jespersen S; Medina C; Té Dda S; da Silva ZJ; Lewin S; Østergaard L; Erikstrup C; Wejse C; Laursen AL; Krarup H;
PLoS One; 2014; 9(6):e99971. PubMed ID: 24915064
[TBL] [Abstract][Full Text] [Related]
36. [The analysis of hepatitis delta virus infective markers in the hepatitis is B virus infective people].
Xu PS; Han SY; Sun CY; Zhao J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):307-9. PubMed ID: 23189853
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis D virus infection, replication and cross-talk with the hepatitis B virus.
Huang CR; Lo SJ
World J Gastroenterol; 2014 Oct; 20(40):14589-97. PubMed ID: 25356023
[TBL] [Abstract][Full Text] [Related]
38. Blocking Entry of Hepatitis B and D Viruses to Hepatocytes as a Novel Immunotherapy for Treating Chronic Infections.
Maravelia P; Frelin L; Ni Y; Caro Pérez N; Ahlén G; Jagya N; Verch G; Verhoye L; Pater L; Johansson M; Pasetto A; Meuleman P; Urban S; Sällberg M
J Infect Dis; 2021 Jan; 223(1):128-138. PubMed ID: 31994701
[TBL] [Abstract][Full Text] [Related]
39. HBV S antigen evolution in the backdrop of HDV infection affects epitope processing and presentation.
Sajjad M; Ali S; Baig S; Sharafat S; Khan BA; Khan S; Mughal N; Abidi SH
J Med Virol; 2021 Jun; 93(6):3714-3729. PubMed ID: 33289144
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.
Béguelin C; Moradpour D; Sahli R; Suter-Riniker F; Lüthi A; Cavassini M; Günthard HF; Battegay M; Bernasconi E; Schmid P; Calmy A; Braun DL; Furrer H; Rauch A; Wandeler G;
J Hepatol; 2017 Feb; 66(2):297-303. PubMed ID: 27746337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
